Rakuten Securities, Inc. Novo Cure LTD Transaction History
Rakuten Securities, Inc.
- $228 Billion
- Q1 2024
A detailed history of Rakuten Securities, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Rakuten Securities, Inc. holds 287 shares of NVCR stock, worth $4,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
287
Previous 307
6.51%
Holding current value
$4,592
Previous $4.58 Million
2.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
278Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$145 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$142 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$53.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$38.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.68B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...